Valneva upsizes stock offering to raise ~€102.9M to fund Lyme/chikungunya vaccines

Sep. 30, 2022 4:39 AM ETValneva SE (VALN), INRLFBy: Ravikash, SA News Editor

Trading charts background


Valneva (NASDAQ:VALN) (OTCPK:INRLF) upsized an offering to raise ~€102.9M (~$99.9M) from the previously expected $40M due to excess demand.

The French vaccine maker is pricing of 21M ordinary shares in a global offering to certain investors consisting of a public offering of

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.